Protagonist Therapeutics, Inc (18) | Uncategorized (7)

Recent Contracts

Description of Protagonist Therapeutics, Inc.s Securities Registered Pursuant to Section 12 of the Exchange Act (Filed With SEC on February 28, 2022)
Arbitration Resolution Agreement, dated August 4th, 2021, by and among Protagonist Therapeutics, Inc. and Zealand Pharma, A/S (Filed With SEC on November 3, 2021)
Description of Protagonist Therapeutics, Inc.s Securities Registered Pursuant to Section 12 of the Exchange Act (Filed With SEC on March 10, 2021)
Description of Protagonist Therapeutics, Inc.s Securities Registered Pursuant to Section 12 of the Exchange Act (Filed With SEC on March 10, 2020)
Protagonist Therapeutics, Inc. Amended and Restated 2018 Inducement Plan (Filed With SEC on February 24, 2020)
Open Market Sale AgreementSM, dated November 27, 2019, by and between Protagonist Therapeutics, Inc. and Jefferies LLC (Filed With SEC on November 27, 2019)
Offer Letter between Protagonist Therapeutics, Inc. and Donald Kalkofen, dated May 20, 2019 (Filed With SEC on May 29, 2019)